{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:51:23Z","timestamp":1793501483105,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03324-6","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T12:53:33Z","timestamp":1762520013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Recent advances in biomarkers for detection and diagnosis of sepsis and organ dysfunction: a comprehensive review"],"prefix":"10.1186","volume":"30","author":[{"given":"Leiyang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"3324_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkaa047","volume":"9","author":"P Zhang","year":"2021","unstructured":"Zhang P, Zou B, Liou YC, Huang C. The pathogenesis and diagnosis of sepsis post burn injury. Burns Trauma. 2021;9:tkaa047.","journal-title":"Burns Trauma"},{"issue":"8","key":"3324_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"5","key":"3324_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1056\/NEJMp1707170","volume":"377","author":"K Reinhart","year":"2017","unstructured":"Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing sepsis as a global health priority - a WHO resolution. N Engl J Med. 2017;377(5):414\u20137.","journal-title":"N Engl J Med"},{"issue":"10219","key":"3324_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200\u201311.","journal-title":"Lancet"},{"issue":"4","key":"3324_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.mcna.2020.02.011","volume":"104","author":"MD Font","year":"2020","unstructured":"Font MD, Thyagarajan B, Khanna AK. Sepsis and septic shock - basics of diagnosis, pathophysiology and clinical decision making. Med Clin North Am. 2020;104(4):573\u201385.","journal-title":"Med Clin North Am"},{"issue":"1","key":"3324_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13049-024-01282-2","volume":"32","author":"RS Pinto-Villalba","year":"2024","unstructured":"Pinto-Villalba RS, Balseca-Arellano D, Leon-Rojas JE. Septic shock in the prehospital setting: a scoping review. Scand J Trauma Resusc Emerg Med. 2024;32(1):113.","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"2","key":"3324_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/CCM.0000000000006135","volume":"52","author":"D De Backer","year":"2024","unstructured":"De Backer D, Deutschman CS, Hellman J, Myatra SN, Ostermann M, Prescott HC, et al. Surviving sepsis campaign research priorities 2023. Crit Care Med. 2024;52(2):268\u201396.","journal-title":"Crit Care Med"},{"issue":"12","key":"3324_CR8","first-page":"16878","volume":"134","author":"M Prucha","year":"2024","unstructured":"Prucha M, Zahorec R. Diagnosis of sepsis: which clinical and laboratory biomarkers are useful? Pol Arch Intern Med. 2024;134(12):16878.","journal-title":"Pol Arch Intern Med"},{"key":"3324_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119891","volume":"562","author":"J Saxena","year":"2024","unstructured":"Saxena J, Das S, Kumar A, Sharma A, Sharma L, Kaushik S, et al. Biomarkers in sepsis. Clin Chim Acta. 2024;562:119891.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"3324_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1055\/s-0044-1787270","volume":"45","author":"EP Plata-Menchaca","year":"2024","unstructured":"Plata-Menchaca EP, Ruiz-Rodriguez JC, Ferrer R. Early diagnosis of sepsis: the role of biomarkers and rapid microbiological tests. Semin Respir Crit Care Med. 2024;45(4):479\u201390.","journal-title":"Semin Respir Crit Care Med"},{"issue":"7","key":"3324_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41581-018-0005-7","volume":"14","author":"C Lelubre","year":"2018","unstructured":"Lelubre C, Vincent JL. Mechanisms and treatment of organ failure in sepsis. Nat Rev Nephrol. 2018;14(7):417\u201327.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"3324_CR12","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1097\/CCM.0000000000005307","volume":"50","author":"T Barichello","year":"2022","unstructured":"Barichello T, Generoso JS, Dominguini D, Corneo E, Giridharan VV, Sahrapour TA, et al. Postmortem evidence of brain inflammatory markers and injury in septic patients: a systematic review. Crit Care Med. 2022;50(3):e241\u201352.","journal-title":"Crit Care Med"},{"issue":"8","key":"3324_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.8686","volume":"2","author":"S Yende","year":"2019","unstructured":"Yende S, Kellum JA, Talisa VB, Peck Palmer OM, Chang CH, Filbin MR, et al. Long-term host immune response trajectories among hospitalized patients with sepsis. JAMA Netw Open. 2019;2(8):e198686.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"3324_CR14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13054-020-02993-5","volume":"24","author":"C Pierrakos","year":"2020","unstructured":"Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent JL. Biomarkers of sepsis: time for a reappraisal. Crit Care. 2020;24(1):287.","journal-title":"Crit Care"},{"issue":"5","key":"3324_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/08850666231194535","volume":"39","author":"M Cohen","year":"2024","unstructured":"Cohen M, Banerjee D. Biomarkers in sepsis: a current review of new technologies. J Intensive Care Med. 2024;39(5):399\u2013405.","journal-title":"J Intensive Care Med"},{"issue":"3","key":"3324_CR16","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4103\/joacp.joacp_560_21","volume":"39","author":"D Juneja","year":"2023","unstructured":"Juneja D, Jain N, Singh O, Goel A, Arora S. Comparison between presepsin, procalcitonin, and CRP as biomarkers to diagnose sepsis in critically ill patients. J Anaesthesiol Clin Pharmacol. 2023;39(3):458\u201362.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"3","key":"3324_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1473-3099(13)70325-6","volume":"14","author":"P Schlattmann","year":"2014","unstructured":"Schlattmann P, Brunkhorst FM. Procalcitonin as a diagnostic marker for sepsis. Lancet Infect Dis. 2014;14(3):189.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"3324_CR18","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1177\/0300060514528483","volume":"42","author":"HX Li","year":"2014","unstructured":"Li HX, Liu ZM, Zhao SJ, Zhang D, Wang SJ, Wang YS. Measuring both procalcitonin and C-reactive protein for a diagnosis of sepsis in critically ill patients. J Int Med Res. 2014;42(4):1050\u20139.","journal-title":"J Int Med Res"},{"issue":"1","key":"3324_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000336629","volume":"102","author":"N Hofer","year":"2012","unstructured":"Hofer N, Zacharias E, Muller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology. 2012;102(1):25\u201336.","journal-title":"Neonatology"},{"issue":"9713","key":"3324_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375(9713):463\u201374.","journal-title":"Lancet"},{"key":"3324_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.intimp.2018.07.024","volume":"62","author":"MH Yu","year":"2018","unstructured":"Yu MH, Chen MH, Han F, Li Q, Sun RH, Tu YX. Prognostic value of the biomarkers serum amyloid A and nitric oxide in patients with sepsis. Int Immunopharmacol. 2018;62:287\u201392.","journal-title":"Int Immunopharmacol"},{"key":"3324_CR22","unstructured":"Cleland DA, Eranki AP, Procalcitonin, StatPearls, Treasure Island (FL) ineligible companies. Disclosure: Ambika Eranki declares no relevant financial relationships with ineligible companies. 2024."},{"issue":"4","key":"3324_CR23","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/SHK.0000000000001900","volume":"57","author":"K Katsaros","year":"2022","unstructured":"Katsaros K, Renieris G, Safarika A, Adami EM, Gkavogianni T, Giannikopoulos G, et al. Heparin binding protein for the early diagnosis and prognosis of sepsis in the emergency department: the prompt multicenter study. Shock. 2022;57(4):518\u201325.","journal-title":"Shock"},{"issue":"25","key":"3324_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038525","volume":"103","author":"AM Taha","year":"2024","unstructured":"Taha AM, Najah Q, Omar MM, Abouelmagd K, Ali M, Hasan MT, et al. Diagnostic and prognostic value of heparin-binding protein in sepsis: a systematic review and meta-analysis. Medicine (Baltimore). 2024;103(25):e38525.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"3324_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-89241-4","volume":"15","author":"Z Mao","year":"2025","unstructured":"Mao Z, Yang W, Gao J, Zhang J, Yang M, Liu H, et al. Accuracy of blood heparin-binding protein (HBP) for diagnosis bacteremia in patients with sepsis. Sci Rep. 2025;15(1):5702.","journal-title":"Sci Rep"},{"issue":"7","key":"3324_CR26","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1097\/CCM.0000000000003137","volume":"46","author":"BJ Kelly","year":"2018","unstructured":"Kelly BJ, Lautenbach E, Nachamkin I, Coffin SE, Gerber JS, Fuchs BD, et al. Combined biomarkers predict acute mortality among critically ill patients with suspected sepsis. Crit Care Med. 2018;46(7):1106\u201313.","journal-title":"Crit Care Med"},{"key":"3324_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117352","volume":"544","author":"H Ling","year":"2023","unstructured":"Ling H, Chen M, Dai J, Zhong H, Chen R, Shi F. Evaluation of qSOFA combined with inflammatory mediators for diagnosing sepsis and predicting mortality among emergency department. Clin Chim Acta. 2023;544:117352.","journal-title":"Clin Chim Acta"},{"key":"3324_CR28","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.2147\/IDR.S384351","volume":"15","author":"B Yu","year":"2022","unstructured":"Yu B, Chen M, Zhang Y, Cao Y, Yang J, Wei B, et al. Diagnostic and prognostic value of interleukin-6 in emergency department sepsis patients. Infect Drug Resist. 2022;15:5557\u201366.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"3324_CR29","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41401-021-00676-7","volume":"43","author":"C Deng","year":"2022","unstructured":"Deng C, Zhao L, Yang Z, Shang JJ, Wang CY, Shen MZ, et al. Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury. Acta Pharmacol Sin. 2022;43(3):520\u20138.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"3324_CR30","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/SHK.0000000000001265","volume":"52","author":"E Karakike","year":"2019","unstructured":"Karakike E, Adami ME, Lada M, Gkavogianni T, Koutelidakis IM, Bauer M, et al. Late peaks of HMGB1 and sepsis outcome: evidence for synergy with chronic inflammatory disorders. Shock. 2019;52(3):334\u20139.","journal-title":"Shock"},{"issue":"4","key":"3324_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2217\/bmm-2022-0899","volume":"17","author":"Y Fan","year":"2023","unstructured":"Fan Y, Ye Z, Tang Y. Serum HMGB1 and soluble urokinase plasminogen activator receptor levels aid diagnosis and prognosis prediction of sepsis with acute respiratory distress syndrome. Biomark Med. 2023;17(4):231\u20139.","journal-title":"Biomark Med"},{"issue":"2","key":"3324_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2174\/1566523219666190621111604","volume":"19","author":"J Zhao","year":"2019","unstructured":"Zhao J, Sun T, Wu S, Liu Y. High mobility group box 1: an immune-regulatory protein. Curr Gene Ther. 2019;19(2):100\u20139.","journal-title":"Curr Gene Ther"},{"key":"3324_CR33","volume":"35","author":"NA Mansour","year":"2023","unstructured":"Mansour NA, Mahmeed AA, Bindayna K. Effect of HMGB1 and HBD-3 levels in the diagnosis of sepsis- a comparative descriptive study. Biochem Biophys Rep. 2023;35:101511.","journal-title":"Biochem Biophys Rep"},{"issue":"2","key":"3324_CR34","first-page":"204","volume":"7","author":"M Amini","year":"2019","unstructured":"Amini M, Pakdaman A, Shapoori S, Mosayebi G. High mobility group box-1 (HMGB1) protein as a biomarker for acute cholecystitis. Rep Biochem Mol Biol. 2019;7(2):204\u20139.","journal-title":"Rep Biochem Mol Biol"},{"key":"3324_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.907387","volume":"13","author":"S Siskind","year":"2022","unstructured":"Siskind S, Brenner M, Wang P. TREM-1 modulation strategies for sepsis. Front Immunol. 2022;13:907387.","journal-title":"Front Immunol"},{"key":"3324_CR36","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.2147\/IDR.S314237","volume":"14","author":"A Nasr El-Din","year":"2021","unstructured":"Nasr El-Din A, Abdel-Gawad AR, Abdelgalil W, Fahmy NF. Evaluation of sTREM1 and suPAR biomarkers as diagnostic and prognostic predictors in sepsis patients. Infect Drug Resist. 2021;14:3495\u2013507.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"3324_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12916-020-01627-5","volume":"18","author":"SW Wright","year":"2020","unstructured":"Wright SW, Lovelace-Macon L, Hantrakun V, Rudd KE, Teparrukkul P, Kosamo S, et al. STREM-1 predicts mortality in hospitalized patients with infection in a tropical, middle-income country. BMC Med. 2020;18(1):159.","journal-title":"BMC Med"},{"issue":"1","key":"3324_CR38","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1186\/s13054-019-2684-2","volume":"23","author":"BJ Anderson","year":"2019","unstructured":"Anderson BJ, Calfee CS, Liu KD, Reilly JP, Kangelaris KN, Shashaty MGS, et al. Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study. Crit Care. 2019;23(1):400.","journal-title":"Crit Care"},{"key":"3324_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2021.105074","volume":"96","author":"Q Qin","year":"2021","unstructured":"Qin Q, Liang L, Xia Y. Diagnostic and prognostic predictive values of circulating sTREM-1 in sepsis: a meta-analysis. Infect Genet Evol. 2021;96:105074.","journal-title":"Infect Genet Evol"},{"issue":"3","key":"3324_CR40","first-page":"578","volume":"45","author":"B Halim","year":"2015","unstructured":"Halim B, Ozlem T, Melek C, Munip Hakan Y, Cevval U, Gonul DH, et al. Diagnostic and prognostic value of procalcitonin and sTREM-1 levels in sepsis. Turk J Med Sci. 2015;45(3):578\u201386.","journal-title":"Turk J Med Sci"},{"issue":"6","key":"3324_CR41","first-page":"1385","volume":"65","author":"EJ Giamarellos-Bourboulis","year":"2008","unstructured":"Giamarellos-Bourboulis EJ, Mouktaroudi M, Tsaganos T, Koutoukas P, Spyridaki E, Pelekanou A, et al. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma. J Trauma. 2008;65(6):1385\u201390.","journal-title":"J Trauma"},{"issue":"1","key":"3324_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13054-024-04825-2","volume":"28","author":"ME Adami","year":"2024","unstructured":"Adami ME, Kotsaki A, Antonakos N, Giannitsioti E, Chalvatzis S, Saridaki M, et al. qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial. Crit Care. 2024;28(1):42.","journal-title":"Crit Care"},{"issue":"4","key":"3324_CR43","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/SHK.0000000000001434","volume":"53","author":"Q Huang","year":"2020","unstructured":"Huang Q, Xiong H, Yan P, Shuai T, Liu J, Zhu L, et al. The diagnostic and prognostic value of suPAR in patients with sepsis: a systematic review and meta-analysis. Shock. 2020;53(4):416\u201325.","journal-title":"Shock"},{"issue":"6","key":"3324_CR44","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/labmed\/lmaa015","volume":"51","author":"W Zhou","year":"2020","unstructured":"Zhou W, Rao H, Ding Q, Lou X, Shen J, Ye B, et al. Soluble CD14 subtype in peripheral blood is a biomarker for early diagnosis of sepsis. Lab Med. 2020;51(6):614\u20139.","journal-title":"Lab Med"},{"key":"3324_CR45","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2019.190508","author":"M Chen","year":"2020","unstructured":"Chen M, Zhu Y. Utility of sTREM-1 and presepsin (sCD14-ST) as diagnostic and prognostic markers of sepsis. Clin Lab. 2020. https:\/\/doi.org\/10.7754\/Clin.Lab.2019.190508.","journal-title":"Clin Lab"},{"issue":"8","key":"3324_CR46","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00134-018-5234-5","volume":"44","author":"J Textoris","year":"2018","unstructured":"Textoris J, Gordon AC. Sepsis: who will shoot first? Pharma or diagnostics? Intensive Care Med. 2018;44(8):1331\u20133.","journal-title":"Intensive Care Med"},{"key":"3324_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58091198","author":"HP Wu","year":"2022","unstructured":"Wu HP, Chuang LP, Liu PH, Chu CM, Yu CC, Lin SW, et al. Decreased monocyte HLA-DR expression in patients with sepsis and acute kidney injury. Medicina (Kaunas). 2022. https:\/\/doi.org\/10.3390\/medicina58091198.","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"3324_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12813","volume":"91","author":"J Xu","year":"2020","unstructured":"Xu J, Li J, Xiao K, Zou S, Yan P, Xie X, et al. Dynamic changes in human HLA-DRA gene expression and Th cell subsets in sepsis: indications of immunosuppression and associated outcomes. Scand J Immunol. 2020;91(1):e12813.","journal-title":"Scand J Immunol"},{"issue":"9","key":"3324_CR49","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1182\/blood.2020009417","volume":"138","author":"JF Wang","year":"2021","unstructured":"Wang JF, Wang YP, Xie J, Zhao ZZ, Gupta S, Guo Y, et al. Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis. Blood. 2021;138(9):806\u201310.","journal-title":"Blood"},{"key":"3324_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/1735-1995.183996","volume":"21","author":"S Li","year":"2016","unstructured":"Li S, Rong H, Guo Q, Chen Y, Zhang G, Yang J. Serum procalcitonin levels distinguish Gram-negative bacterial sepsis from Gram-positive bacterial and fungal sepsis. J Res Med Sci. 2016;21:39.","journal-title":"J Res Med Sci"},{"issue":"1","key":"3324_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51414-y","volume":"14","author":"M Li","year":"2024","unstructured":"Li M, Qin YJ, Zhang XL, Zhang CH, Ci RJ, Chen W, et al. A biomarker panel of C-reactive protein, procalcitonin and serum amyloid A is a predictor of sepsis in severe trauma patients. Sci Rep. 2024;14(1):628.","journal-title":"Sci Rep"},{"issue":"4","key":"3324_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jinf.2021.02.019","volume":"82","author":"L Velly","year":"2021","unstructured":"Velly L, Volant S, Fitting C, Ghazali DA, Salipante F, Mayaux J, et al. Optimal combination of early biomarkers for infection and sepsis diagnosis in the emergency department: the BIPS study. J Infect. 2021;82(4):11\u201321.","journal-title":"J Infect"},{"issue":"1","key":"3324_CR53","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/imr.12570","volume":"280","author":"M Erreni","year":"2017","unstructured":"Erreni M, Manfredi AA, Garlanda C, Mantovani A, Rovere-Querini P. The long pentraxin PTX3: a prototypical sensor of tissue injury and a regulator of homeostasis. Immunol Rev. 2017;280(1):112\u201325.","journal-title":"Immunol Rev"},{"issue":"22","key":"3324_CR54","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020495","volume":"99","author":"J Song","year":"2020","unstructured":"Song J, Moon S, Park DW, Cho HJ, Kim JY, Park J, et al. Biomarker combination and SOFA score for the prediction of mortality in sepsis and septic shock: a prospective observational study according to the Sepsis-3 definitions. Medicine (Baltimore). 2020;99(22):e20495.","journal-title":"Medicine (Baltimore)"},{"key":"3324_CR55","doi-asserted-by":"publisher","first-page":"1673572","DOI":"10.1155\/2022\/1673572","volume":"2022","author":"M Lin","year":"2022","unstructured":"Lin M, Zhang L, Tang X, Tang Y. The value of neutrophil\/lymphocyte ratio combined with red blood cell distribution width in evaluating the prognosis of emergency patients with sepsis. Emerg Med Int. 2022;2022:1673572.","journal-title":"Emerg Med Int"},{"issue":"1","key":"3324_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.15441\/ceem.24.211","volume":"12","author":"S Pandey","year":"2025","unstructured":"Pandey S. Advances in metabolomics in critically ill patients with sepsis and septic shock. Clin Exp Emerg Med. 2025;12(1):4\u201315.","journal-title":"Clin Exp Emerg Med"},{"issue":"3","key":"3324_CR57","doi-asserted-by":"publisher","first-page":"270","DOI":"10.7150\/ntno.94071","volume":"8","author":"S Pandey","year":"2024","unstructured":"Pandey S. Sepsis management & advances in metabolomics. Nanotheranostics. 2024;8(3):270\u201384.","journal-title":"Nanotheranostics"},{"issue":"1","key":"3324_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-03920-7","volume":"23","author":"P Huang","year":"2025","unstructured":"Huang P, Liu Y, Li Y, Xin Y, Nan C, Luo Y, et al. Metabolomics- and proteomics-based multi-omics integration reveals early metabolite alterations in sepsis-associated acute kidney injury. BMC Med. 2025;23(1):79.","journal-title":"BMC Med"},{"issue":"1","key":"3324_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92631-3","volume":"15","author":"Y Gou","year":"2025","unstructured":"Gou Y, Lv BH, Zhang JF, Li SM, Hei XP, Liu JJ, et al. Identifying early predictive and diagnostic biomarkers and exploring metabolic pathways for sepsis after trauma based on an untargeted metabolomics approach. Sci Rep. 2025;15(1):12068.","journal-title":"Sci Rep"},{"issue":"2","key":"3324_CR60","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1039\/D0MO00177E","volume":"17","author":"S Pandey","year":"2021","unstructured":"Pandey S, Adnan Siddiqui M, Azim A, Trigun SK, Sinha N. Serum metabolic profiles of septic shock patients based upon co-morbidities and other underlying conditions. Mol Omics. 2021;17(2):260\u201376.","journal-title":"Mol Omics"},{"issue":"2","key":"3324_CR61","doi-asserted-by":"publisher","first-page":"142","DOI":"10.7150\/ntno.79394","volume":"7","author":"S Pandey","year":"2023","unstructured":"Pandey S, Azim A, Sinha N. Longitudinal NMR based serum metabolomics to track the potential serum biomarkers of septic shock. Nanotheranostics. 2023;7(2):142\u201351.","journal-title":"Nanotheranostics"},{"key":"3324_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1309719","volume":"11","author":"AB Liu","year":"2023","unstructured":"Liu AB, Li SJ, Yu YY, Zhang JF, Ma L. Current insight on the mechanisms of programmed cell death in sepsis-induced myocardial dysfunction. Front Cell Dev Biol. 2023;11:1309719.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"3324_CR63","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ihj.2020.07.020","volume":"72","author":"R Prasad","year":"2020","unstructured":"Prasad R, Kumar A, Jain D, Das BK, Singh UK, Singh TB. Echocardiography versus cardiac biomarkers for myocardial dysfunction in children with scorpion envenomation: an observational study from tertiary care center in northern India. Indian Heart J. 2020;72(5):431\u20134.","journal-title":"Indian Heart J"},{"issue":"7","key":"3324_CR64","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1631\/jzus.B2000049","volume":"21","author":"FC Chen","year":"2020","unstructured":"Chen FC, Xu YC, Zhang ZC. Multi-biomarker strategy for prediction of myocardial dysfunction and mortality in sepsis. J Zhejiang Univ Sci B. 2020;21(7):537\u201348.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"11","key":"3324_CR65","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00380-021-01865-4","volume":"36","author":"K Tani","year":"2021","unstructured":"Tani K, Shirakabe A, Kobayashi N, Okazaki H, Matsushita M, Shibata Y, et al. The prognostic impact of the serum heart-type fatty acid-binding protein level in patients with sepsis who were admitted to the non-surgical intensive-care unit. Heart Vessels. 2021;36(11):1765\u201374.","journal-title":"Heart Vessels"},{"issue":"1","key":"3324_CR66","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12944-024-02264-0","volume":"23","author":"X Chang","year":"2024","unstructured":"Chang X, Guo Y, Wang J, Liu J, Ma Y, Lu Q, et al. Heart-type fatty acid binding protein (H-FABP) as an early biomarker in sepsis-induced cardiomyopathy: a prospective observational study. Lipids Health Dis. 2024;23(1):283.","journal-title":"Lipids Health Dis"},{"issue":"8","key":"3324_CR67","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/07853890.2020.1800075","volume":"52","author":"H Goel","year":"2020","unstructured":"Goel H, Melot J, Krinock MD, Kumar A, Nadar SK, Lip GYH. Heart-type fatty acid-binding protein: an overlooked cardiac biomarker. Ann Med. 2020;52(8):444\u201361.","journal-title":"Ann Med"},{"key":"3324_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010164","author":"R Rezar","year":"2020","unstructured":"Rezar R, Jirak P, Gschwandtner M, Derler R, Felder TK, Haslinger M, et al. Heart-type fatty acid-binding protein (H-FABP) and its role as a biomarker in heart failure: what do we know so far? J Clin Med. 2020. https:\/\/doi.org\/10.3390\/jcm9010164.","journal-title":"J Clin Med"},{"key":"3324_CR69","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000002678","author":"L Yang","year":"2025","unstructured":"Yang L, Feng JK, Gong PX, Yao LN, Li P. Advances in research pertaining to biomarkers for myocardial injury in sepsis. Shock. 2025. https:\/\/doi.org\/10.1097\/SHK.0000000000002678.","journal-title":"Shock"},{"issue":"1","key":"3324_CR70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41420-021-00429-9","volume":"7","author":"S Awasthi","year":"2021","unstructured":"Awasthi S, Wagner T, Venkatakrishnan AJ, Puranik A, Hurchik M, Agarwal V, et al. Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients. Cell Death Discov. 2021;7(1):55.","journal-title":"Cell Death Discov"},{"issue":"3","key":"3324_CR71","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.chest.2020.03.041","volume":"158","author":"MK Dahmer","year":"2020","unstructured":"Dahmer MK, Flori H, Sapru A, Kohne J, Weeks HM, Curley MAQ, et al. Surfactant Protein D is associated with severe pediatric ARDS, prolonged ventilation, and death in children with acute respiratory failure. Chest. 2020;158(3):1027\u201335.","journal-title":"Chest"},{"issue":"1","key":"3324_CR72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5644\/ama2006-124.366","volume":"51","author":"A Agustama","year":"2022","unstructured":"Agustama A, Surgean Veterini A, Utariani A. Correlation of surfactant protein-D (SP-D) serum levels with ARDS severity and mortality in Covid-19 patients in Indonesia. Acta Med Acad. 2022;51(1):21\u20138.","journal-title":"Acta Med Acad"},{"key":"3324_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22262","author":"J Lin","year":"2018","unstructured":"Lin J, Zhang W, Wang L, Tian F. Diagnostic and prognostic values of Club cell protein 16 (CC16) in critical care patients with acute respiratory distress syndrome. J Clin Lab Anal. 2018. https:\/\/doi.org\/10.1002\/jcla.22262.","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"3324_CR74","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1097\/CCM.0b013e3182451c87","volume":"40","author":"CS Calfee","year":"2012","unstructured":"Calfee CS, Gallagher D, Abbott J, Thompson BT, Matthay MA, Network NA. Plasma angiopoietin-2 in clinical acute lung injury: prognostic and pathogenetic significance. Crit Care Med. 2012;40(6):1731\u20137.","journal-title":"Crit Care Med"},{"issue":"2","key":"3324_CR75","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1089\/sur.2017.261","volume":"19","author":"SJ Skube","year":"2018","unstructured":"Skube SJ, Katz SA, Chipman JG, Tignanelli CJ. Acute kidney injury and sepsis. Surg Infect. 2018;19(2):216\u201324.","journal-title":"Surg Infect"},{"issue":"1","key":"3324_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61434-z","volume":"10","author":"P Nesargi","year":"2020","unstructured":"Nesargi P, Niranjan HS, Bandiya P, Benakappa N. Neutrophil volume, conductivity and scatter (VCS) as a screening tool in neonatal sepsis. Sci Rep. 2020;10(1):4457.","journal-title":"Sci Rep"},{"issue":"3","key":"3324_CR77","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s00134-009-1724-9","volume":"36","author":"SM Bagshaw","year":"2010","unstructured":"Bagshaw SM, Bennett M, Haase M, Haase-Fielitz A, Egi M, Morimatsu H, et al. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med. 2010;36(3):452\u201361.","journal-title":"Intensive Care Med"},{"issue":"8","key":"3324_CR78","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1164\/rccm.201401-0077OC","volume":"189","author":"A Bihorac","year":"2014","unstructured":"Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med. 2014;189(8):932\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"3324_CR79","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.19209","volume":"3","author":"M Ostermann","year":"2020","unstructured":"Ostermann M, Zarbock A, Goldstein S, Kashani K, Macedo E, Murugan R, et al. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw Open. 2020;3(10):e2019209.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"3324_CR80","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","volume":"96","author":"S Peerapornratana","year":"2019","unstructured":"Peerapornratana S, Manrique-Caballero CL, Gomez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019;96(5):1083\u201399.","journal-title":"Kidney Int"},{"issue":"3","key":"3324_CR81","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","volume":"193","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med. 2016;193(3):259\u201372.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 8","key":"3324_CR82","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.12.79","volume":"7","author":"M Kluge","year":"2019","unstructured":"Kluge M, Tacke F. Liver impairment in critical illness and sepsis: the dawn of new biomarkers? Ann Transl Med. 2019;7(Suppl 8):S258.","journal-title":"Ann Transl Med"},{"issue":"36","key":"3324_CR83","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007547","volume":"96","author":"AC Inkaya","year":"2017","unstructured":"Inkaya AC, Demir NA, Kolgelier S, Sumer S, Demir LS, Ural O, et al. Is serum high-mobility group box 1 (HMGB-1) level correlated with liver fibrosis in chronic hepatitis B? Medicine. 2017;96(36):e7547.","journal-title":"Medicine"},{"key":"3324_CR84","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/IDR.S499643","volume":"18","author":"J Wang","year":"2025","unstructured":"Wang J, Jiang Y, Yuan Y, Ma X, Li T, Lv Y, et al. Serum exosomes miR-122-5p induces hepatic and renal injury in septic rats by regulating TAK1\/SIRT1 pathway. Infect Drug Resist. 2025;18:185\u201397.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"3324_CR85","first-page":"165","volume":"20","author":"O Alhaddad","year":"2025","unstructured":"Alhaddad O, Elsabaawy M, Salah A, Hendy O, Elsabaawy D, Mazaly M, et al. Evaluation of glutamate dehydrogenase (GLDH) as a diagnostic and prognostic marker in drug-induced liver injury. Prz Gastroenterol. 2025;20(2):165\u201372.","journal-title":"Prz Gastroenterol"},{"issue":"1","key":"3324_CR86","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00535-004-1493-8","volume":"40","author":"A Hiraoka","year":"2005","unstructured":"Hiraoka A, Horiike N, Akbar SM, Michitaka K, Matsuyama T, Onji M. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure. J Gastroenterol. 2005;40(1):52\u20136.","journal-title":"J Gastroenterol"},{"issue":"21","key":"3324_CR87","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.3390\/ijms20215314","volume":"20","author":"B Khambu","year":"2019","unstructured":"Khambu B, Yan S, Huda N, Yin XM. Role of high-mobility group box-1 in liver pathogenesis. Int J Mol Sci. 2019;20(21):5314.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3324_CR88","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.jhep.2010.04.029","volume":"53","author":"LP Bechmann","year":"2010","unstructured":"Bechmann LP, Jochum C, Kocabayoglu P, Sowa JP, Kassalik M, Gieseler RK, et al. Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J Hepatol. 2010;53(4):639\u201347.","journal-title":"J Hepatol"},{"issue":"2","key":"3324_CR89","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/jth.13911","volume":"16","author":"T Iba","year":"2018","unstructured":"Iba T, Levy JH. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis. J Thromb Haemost. 2018;16(2):231\u201341.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"3324_CR90","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1055\/s-0042-1758791","volume":"49","author":"GB Morrow","year":"2023","unstructured":"Morrow GB, Mutch NJ. Past, present, and future perspectives of plasminogen activator inhibitor 1 (PAI-1). Semin Thromb Hemost. 2023;49(3):305\u201313.","journal-title":"Semin Thromb Hemost"},{"issue":"11","key":"3324_CR91","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/jth.14578","volume":"17","author":"T Iba","year":"2019","unstructured":"Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M, et al. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost. 2019;17(11):1989\u201394.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"3324_CR92","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/jth.14482","volume":"17","author":"T Iba","year":"2019","unstructured":"Iba T, Levy JH, Yamakawa K, Thachil J, Warkentin TE, Levi M, et al. Proposal of a two-step process for the diagnosis of sepsis-induced disseminated intravascular coagulation. J Thromb Haemost. 2019;17(8):1265\u20138.","journal-title":"J Thromb Haemost"},{"issue":"Pt A","key":"3324_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110800","volume":"124","author":"Y Hong","year":"2023","unstructured":"Hong Y, Chen P, Gao J, Lin Y, Chen L, Shang X. Sepsis-associated encephalopathy: from pathophysiology to clinical management. Int Immunopharmacol. 2023;124(Pt A):110800.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"3324_CR94","first-page":"778","volume":"65","author":"KM Lumpkins","year":"2008","unstructured":"Lumpkins KM, Bochicchio GV, Keledjian K, Simard JM, McCunn M, Scalea T. Glial fibrillary acidic protein is highly correlated with brain injury. J Trauma. 2008;65(4):778\u201382 (discussion 782-4).","journal-title":"J Trauma"},{"issue":"3","key":"3324_CR95","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/ana.26004","volume":"89","author":"R Sutter","year":"2021","unstructured":"Sutter R, Hert L, De Marchis GM, Twerenbold R, Kappos L, Naegelin Y, et al. Serum neurofilament light chain levels in the intensive care unit: comparison between severely ill patients with and without coronavirus disease 2019. Ann Neurol. 2021;89(3):610\u20136.","journal-title":"Ann Neurol"},{"issue":"6","key":"3324_CR96","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s10753-021-01501-3","volume":"44","author":"Q Gao","year":"2021","unstructured":"Gao Q, Hernandes MS. Sepsis-associated encephalopathy and blood-brain barrier dysfunction. Inflammation. 2021;44(6):2143\u201350.","journal-title":"Inflammation"},{"issue":"1","key":"3324_CR97","doi-asserted-by":"publisher","first-page":"1840912","DOI":"10.1080\/21688370.2020.1840912","volume":"9","author":"T Barichello","year":"2021","unstructured":"Barichello T, Generoso JS, Collodel A, Petronilho F, Dal-Pizzol F. The blood-brain barrier dysfunction in sepsis. Tissue Barriers. 2021;9(1):1840912.","journal-title":"Tissue Barriers"},{"issue":"3","key":"3324_CR98","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/SHK.0000000000000524","volume":"45","author":"GJ Zhao","year":"2016","unstructured":"Zhao GJ, Li D, Zhao Q, Lian J, Hu TT, Hong GL, et al. Prognostic value of plasma tight-junction proteins for sepsis in emergency department: an observational study. Shock. 2016;45(3):326\u201332.","journal-title":"Shock"},{"key":"3324_CR99","doi-asserted-by":"publisher","first-page":"1102126","DOI":"10.3389\/fimmu.2023.1102126","volume":"14","author":"J Hu","year":"2023","unstructured":"Hu J, Xie S, Li W, Zhang L. Diagnostic and prognostic value of serum S100B in sepsis-associated encephalopathy: a systematic review and meta-analysis. Front Immunol. 2023;14:1102126.","journal-title":"Front Immunol"},{"key":"3324_CR100","doi-asserted-by":"publisher","first-page":"1377817","DOI":"10.3389\/fimmu.2024.1377817","volume":"15","author":"P Xu","year":"2024","unstructured":"Xu P, Tao Z, Zhang C. Integrated multi-omics and artificial intelligence to explore new neutrophils clusters and potential biomarkers in sepsis with experimental validation. Front Immunol. 2024;15:1377817.","journal-title":"Front Immunol"},{"issue":"1","key":"3324_CR101","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s13054-025-05588-0","volume":"29","author":"P Papareddy","year":"2025","unstructured":"Papareddy P, Lobo TJ, Holub M, Bouma H, Maca J, Strodthoff N, et al. Transforming sepsis management: AI-driven innovations in early detection and tailored therapies. Crit Care. 2025;29(1):366.","journal-title":"Crit Care"},{"key":"3324_CR102","doi-asserted-by":"publisher","first-page":"1247131","DOI":"10.3389\/fimmu.2023.1247131","volume":"14","author":"W Dai","year":"2023","unstructured":"Dai W, Zheng P, Wu J, Chen S, Deng M, Tong X, et al. Integrated analysis of single-cell RNA-seq and chipset data unravels PANoptosis-related genes in sepsis. Front Immunol. 2023;14:1247131.","journal-title":"Front Immunol"},{"issue":"3","key":"3324_CR103","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1080\/02648725.2023.2196475","volume":"40","author":"Q Mo","year":"2024","unstructured":"Mo Q, Mo Q, Mo F. Single-cell RNA sequencing and transcriptomic analysis reveal key genes and regulatory mechanisms in sepsis. Biotechnol Genet Eng Rev. 2024;40(3):1636\u201358.","journal-title":"Biotechnol Genet Eng Rev"},{"key":"3324_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104394","volume":"86","author":"M Komorowski","year":"2022","unstructured":"Komorowski M, Green A, Tatham KC, Seymour C, Antcliffe D. Sepsis biomarkers and diagnostic tools with a focus on machine learning. EBioMedicine. 2022;86:104394.","journal-title":"EBioMedicine"},{"issue":"11","key":"3324_CR105","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1007\/s12519-023-00717-7","volume":"19","author":"WY Zhang","year":"2023","unstructured":"Zhang WY, Chen ZH, An XX, Li H, Zhang HL, Wu SJ, et al. Analysis and validation of diagnostic biomarkers and immune cell infiltration characteristics in pediatric sepsis by integrating bioinformatics and machine learning. World J Pediatr. 2023;19(11):1094\u2013103.","journal-title":"World J Pediatr"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03324-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03324-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03324-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:04:21Z","timestamp":1762524261000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03324-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3324"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03324-6","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1081"}}